Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Cancer Discovery|May 12, 2019
Rational Targeting of Cooperating Layers of the Epigenome Yields Enhanced Therapeutic Efficacy against AMLCihangir Duy, Matt Teater, Francine E Garrett-Bakelman, et al.Cell|July 4, 2020
TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory FateLeandro Venturutti, Matt Teater, Andrew Zhai, et al.Nature Cancer|February 11, 2021
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencingSara Parsa, Ana Ortega-Molina, Hsia-Yuan Ying, et al.Cancer Discovery|January 10, 2020
Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in LymphomaPatrizia Mondello, Saber Tadros, Matt Teater, et al.Cancer Discovery|October 14, 2016
CREBBP Inactivation Promotes the Development of HDAC3-Dependent LymphomasYanwen Jiang, Ana Ortega-Molina, Huimin Geng, et al.Nature|December 10, 2020
Histone H1 loss drives lymphoma by disrupting 3D chromatin architectureNevin Yusufova, Andreas Kloetgen, Matt Teater, et al.Nature Medicine|October 6, 2015
Loss of BAP1 function leads to EZH2-dependent transformationLindsay M LaFave, Wendy Béguelin, Richard Koche, et al.Cancer Discovery|October 3, 2018
TET2 Deficiency Causes Germinal Center Hyperplasia, Impairs Plasma Cell Differentiation, and Promotes B-cell LymphomagenesisPilar M Dominguez, Hussein Ghamlouch, Wojciech Rosikiewicz, et al.Cancer Cell|May 18, 2013
EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformationWendy Béguelin, Relja Popovic, Matt Teater, et al.Science (New York, N.Y.)|January 19, 2023
BTG1 mutation yields supercompetitive B cells primed for malignant transformationCoraline Mlynarczyk, Matt Teater, Juhee Pae, et al.Pageof 4